Moroccan Medicinal plants as inhibitors against SARS-CoV-2 main protease: Computational investigations

被引:237
|
作者
Aanouz, I. [1 ]
Belhassan, A. [1 ]
El-Khatabi, K. [1 ]
Lakhlifi, T. [1 ]
El-Idrissi, M. [1 ]
Bouachrine, M. [1 ,2 ]
机构
[1] Moulay Ismail Univ Meknes, Mol Chem & Nat Subst Lab, Fac Sci, Meknes, Morocco
[2] Sultan Moulay Sliman Univ, EST Khenifra, Khenifra, Morocco
来源
关键词
Molecular docking; CoV-2019; natural herbal; crocin; digitoxigenin; beta-eudesmol; ACUTE RESPIRATORY SYNDROME; DOCKING;
D O I
10.1080/07391102.2020.1758790
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The new Corona-virus, recently called the severe acute respiratory syndrome Coronavirus (SARS-CoV-2) appears for the first time in China and more precisely in Wuhan (December 2019). This disease can be fatal. Seniors, and people with other medical conditions (diabetes, heart disease horizontal ellipsis ), may be more vulnerable and become seriously ill. This is why research into drugs to treat this infection remains essential in several research laboratories. Natural herbal remedies have long been the main, if not the only, remedy in the oral tradition for treating illnesses. Modern medicine has known its success thanks to traditional medicine, the effectiveness of which derives from medicinal plants. The objective of this study is to determine if the components of natural origin have an anti-viral effect and which can prevent humans from infection by this coronavirus using the most reliable method is molecular docking, which used to find the interaction between studied molecules and the protein, in our case we based on the inhibitor of Coronavirus (nCoV-2019) main protease. The results of molecular docking showed that among 67 molecules of natural origin, three molecules (Crocin, Digitoxigenin, and beta-Eudesmol) are proposed as inhibitors against the coronavirus based on the energy types of interaction between these molecules and studied protein. [GRAPHICS] .
引用
收藏
页码:2971 / 2979
页数:9
相关论文
共 50 条
  • [31] Discovery and Mechanism of SARS-CoV-2 Main Protease Inhibitors
    Huff, Sarah
    Kummetha, Indrasena Reddy
    Tiwari, Shashi Kant
    Huante, Matthew B.
    Clark, Alex E.
    Wang, Shaobo
    Bray, William
    Smith, Davey
    Carlin, Aaron F.
    Endsley, Mark
    Rana, Tariq M.
    JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (04) : 2866 - 2879
  • [32] In silico screening of potential antiviral inhibitors against SARS-CoV-2 main protease
    Palanisamy, Kandhan
    Maiyelvaganan, K. Rudharachari
    Kamalakannan, Shanmugasundaram
    Thilagavathi, Ramasamy
    Selvam, Chelliah
    Prakash, Muthuramalingam
    MOLECULAR SIMULATION, 2023, 49 (02) : 175 - 185
  • [33] Potent and biostable inhibitors of the main protease of SARS-CoV-2
    Tsuji, Kohei
    Ishii, Takahiro
    Kobayakawa, Takuya
    Higashi-Kuwata, Nobuyo
    Azuma, Chika
    Nakayama, Miyuki
    Onishi, Takato
    Nakano, Hiroki
    Wada, Naoya
    Hori, Miki
    Shinohara, Kouki
    Miura, Yutaro
    Kawada, Takuma
    Hayashi, Hironori
    Hattori, Shin-ichiro
    Bulut, Haydar
    Das, Debananda
    Takamune, Nobutoki
    Kishimoto, Naoki
    Saruwatari, Junji
    Okamura, Tadashi
    Nakano, Kenta
    Misumi, Shogo
    Mitsuya, Hiroaki
    Tamamura, Hirokazu
    ISCIENCE, 2022, 25 (11)
  • [34] Fullerene derivatives as inhibitors of the SARS-CoV-2 main protease
    Katagishi, Daiki
    Yasuda, Daisuke
    Takahashi, Kyoko
    Nakamura, Shigeo
    Mashino, Tadahiko
    Ohe, Tomoyuki
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2023, 80
  • [35] Biochemical screening for SARS-CoV-2 main protease inhibitors
    Coelho, Camila
    Gallo, Gloria
    Campos, Claudia B.
    Hardy, Leon
    Wurtele, Martin
    PLOS ONE, 2020, 15 (10):
  • [36] Drug repurposing and computational modeling for discovery of inhibitors of the main protease (Mpro) of SARS-CoV-2
    Silva, Jose Rogerio A.
    Kruger, Hendrik G.
    Molfetta, Fabio A.
    RSC ADVANCES, 2021, 11 (38) : 23450 - 23458
  • [37] Biological Efficacy of 40 Noncovalent SARS-CoV-2 Main Protease Inhibitors: A Computational Study
    Joshi, Sravani
    Srivastava, Ruby
    IRANIAN JOURNAL OF SCIENCE, 2025, 49 (02) : 307 - 318
  • [38] Computational studies on the design of NCI natural products as inhibitors to SARS-CoV-2 main protease
    Durgam, Laxman
    Guruprasad, Lalitha
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2023, 41 (09): : 3741 - 3751
  • [39] Exploring the Potential of Vortioxetine Derivatives as Inhibitors of SARS-CoV-2 Main Protease: A Computational Study
    Zhou, Aizhen
    Wang, Li
    Zou, Jie
    Ma, Shuwei
    Zhou, Yahong
    Wang, Juan
    Li, Na
    Cheng, Bin
    CHEMISTRYSELECT, 2023, 8 (41):
  • [40] Autochthonous Peruvian Natural Plants as Potential SARS-CoV-2 Mpro Main Protease Inhibitors
    Peralta-Moreno, Maria Nuria
    Anton-Munoz, Vanessa
    Ortega-Alarcon, David
    Jimenez-Alesanco, Ana
    Vega, Sonia
    Abian, Olga
    Velazquez-Campoy, Adrian
    Thomson, Timothy M.
    Granadino-Roldan, Jose Manuel
    Machicado, Claudia
    Rubio-Martinez, Jaime
    PHARMACEUTICALS, 2023, 16 (04)